gaa:douglas pharm, page-2

Douglas a well-established and successful New Zealand firm with world-wide markets for its products, a perfect fit for GAA and probably an easy way for Douglas to be listed without having to go through an IPO. They claim the generic drug market is worth $2bn over the next few years and GAA already aggressively pursuing profits with their generic drugs.
GAA haven't really taken a step back since listing and this looks yet another positive step forward. I'm very happy to be holding